Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist Dimerix Limited (ASX: DXB)Mission will receive up to U ...
Google LiteRT.js, released July 9, 2026, brings native browser AI inference to web developers by compiling Google’s proven ...
Spread the love“`html Google Sheets has become a go-to tool for individuals and businesses alike, thanks to its powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results